[
    {
        "text": "controversial new treatment for",
        "start": 0.16,
        "duration": 3.68
    },
    {
        "text": "alzheimer's has been approved by",
        "start": 2.159,
        "duration": 3.841
    },
    {
        "text": "regulators in the united states",
        "start": 3.84,
        "duration": 3.6
    },
    {
        "text": "the treatment which is approved by the",
        "start": 6.0,
        "duration": 4.32
    },
    {
        "text": "u.s food and drug administration or fda",
        "start": 7.44,
        "duration": 4.88
    },
    {
        "text": "is the first for the disease after",
        "start": 10.32,
        "duration": 3.84
    },
    {
        "text": "nearly two decades of",
        "start": 12.32,
        "duration": 5.2
    },
    {
        "text": "failed efforts adu kanumab targets the",
        "start": 14.16,
        "duration": 5.52
    },
    {
        "text": "underlying cause of alzheimer's the most",
        "start": 17.52,
        "duration": 3.759
    },
    {
        "text": "common form of dementia",
        "start": 19.68,
        "duration": 4.24
    },
    {
        "text": "attacking the disease process rather",
        "start": 21.279,
        "duration": 4.561
    },
    {
        "text": "than just easing symptoms",
        "start": 23.92,
        "duration": 3.679
    },
    {
        "text": "patient groups have campaigned for its",
        "start": 25.84,
        "duration": 3.199
    },
    {
        "text": "approval but it's a",
        "start": 27.599,
        "duration": 3.6
    },
    {
        "text": "contentious decision some experts and",
        "start": 29.039,
        "duration": 4.561
    },
    {
        "text": "the fda's independent advisory committee",
        "start": 31.199,
        "duration": 5.121
    },
    {
        "text": "advised against it being approved we'll",
        "start": 33.6,
        "duration": 4.959
    },
    {
        "text": "hear both those perspectives in a moment",
        "start": 36.32,
        "duration": 4.079
    },
    {
        "text": "but first our medical editor fergus",
        "start": 38.559,
        "duration": 4.881
    },
    {
        "text": "walsh has this report",
        "start": 40.399,
        "duration": 6.0
    },
    {
        "text": "this is an historic moment in the battle",
        "start": 43.44,
        "duration": 3.439
    },
    {
        "text": "against",
        "start": 46.399,
        "duration": 3.361
    },
    {
        "text": "alzheimer's for the first time a drug",
        "start": 46.879,
        "duration": 3.921
    },
    {
        "text": "has been approved",
        "start": 49.76,
        "duration": 3.6
    },
    {
        "text": "which tackles not just the symptoms but",
        "start": 50.8,
        "duration": 3.52
    },
    {
        "text": "the underlying",
        "start": 53.36,
        "duration": 3.76
    },
    {
        "text": "cause of this devastating disease",
        "start": 54.32,
        "duration": 3.84
    },
    {
        "text": "adukanemab",
        "start": 57.12,
        "duration": 3.599
    },
    {
        "text": "is not yet licensed in the uk and",
        "start": 58.16,
        "duration": 3.12
    },
    {
        "text": "available",
        "start": 60.719,
        "duration": 3.281
    },
    {
        "text": "only as part of a clinical trial like",
        "start": 61.28,
        "duration": 3.199
    },
    {
        "text": "here",
        "start": 64.0,
        "duration": 2.799
    },
    {
        "text": "at the national hospital for neurology",
        "start": 64.479,
        "duration": 5.201
    },
    {
        "text": "in central london",
        "start": 66.799,
        "duration": 2.881
    },
    {
        "text": "aldo chireza who's 68 was diagnosed with",
        "start": 70.64,
        "duration": 5.76
    },
    {
        "text": "alzheimer's 10 years ago",
        "start": 74.24,
        "duration": 5.28
    },
    {
        "text": "and had to stop working as a surgeon he",
        "start": 76.4,
        "duration": 4.719
    },
    {
        "text": "receives adukanymab",
        "start": 79.52,
        "duration": 4.639
    },
    {
        "text": "every month via infusion and",
        "start": 81.119,
        "duration": 6.241
    },
    {
        "text": "is certain it's helped him i felt",
        "start": 84.159,
        "duration": 5.521
    },
    {
        "text": "that i was uh i wasn't getting so mixed",
        "start": 87.36,
        "duration": 3.36
    },
    {
        "text": "up",
        "start": 89.68,
        "duration": 3.119
    },
    {
        "text": "my my cognitive tests were improving",
        "start": 90.72,
        "duration": 3.6
    },
    {
        "text": "quite quite markedly",
        "start": 92.799,
        "duration": 3.921
    },
    {
        "text": "two years ago andy kanama was written",
        "start": 94.32,
        "duration": 3.2
    },
    {
        "text": "off as a",
        "start": 96.72,
        "duration": 3.359
    },
    {
        "text": "failure and the trial aldo was taking",
        "start": 97.52,
        "duration": 3.279
    },
    {
        "text": "part in",
        "start": 100.079,
        "duration": 3.521
    },
    {
        "text": "was abandoned but the manufacturers",
        "start": 100.799,
        "duration": 3.68
    },
    {
        "text": "biogen",
        "start": 103.6,
        "duration": 3.92
    },
    {
        "text": "analyzed more data and concluded those",
        "start": 104.479,
        "duration": 4.721
    },
    {
        "text": "on the highest doses",
        "start": 107.52,
        "duration": 6.32
    },
    {
        "text": "had better cognition memory and language",
        "start": 109.2,
        "duration": 6.559
    },
    {
        "text": "this is the brain of someone with",
        "start": 113.84,
        "duration": 5.12
    },
    {
        "text": "early alzheimer's the red areas show a",
        "start": 115.759,
        "duration": 4.081
    },
    {
        "text": "buildup of",
        "start": 118.96,
        "duration": 4.159
    },
    {
        "text": "amyloid a protein which can form toxic",
        "start": 119.84,
        "duration": 6.48
    },
    {
        "text": "deposits this is the same individual",
        "start": 123.119,
        "duration": 7.84
    },
    {
        "text": "after a significant amounts of amyloid",
        "start": 126.32,
        "duration": 7.2
    },
    {
        "text": "have been cleared this is the first",
        "start": 130.959,
        "duration": 4.401
    },
    {
        "text": "potential treatment",
        "start": 133.52,
        "duration": 4.32
    },
    {
        "text": "that can tackle the underlying causes of",
        "start": 135.36,
        "duration": 4.8
    },
    {
        "text": "the disease and so for this reason",
        "start": 137.84,
        "duration": 4.32
    },
    {
        "text": "this really is quite a pivotal moment",
        "start": 140.16,
        "duration": 4.24
    },
    {
        "text": "for alzheimer's disease",
        "start": 142.16,
        "duration": 5.12
    },
    {
        "text": "in recent years over a hundred promising",
        "start": 144.4,
        "duration": 4.32
    },
    {
        "text": "alzheimer's drugs",
        "start": 147.28,
        "duration": 4.319
    },
    {
        "text": "have flopped so to now have a medicine",
        "start": 148.72,
        "duration": 4.239
    },
    {
        "text": "that can potentially",
        "start": 151.599,
        "duration": 4.881
    },
    {
        "text": "slow the disease is a huge moment",
        "start": 152.959,
        "duration": 5.28
    },
    {
        "text": "and will encourage scientists to",
        "start": 156.48,
        "duration": 3.2
    },
    {
        "text": "redouble their efforts",
        "start": 158.239,
        "duration": 4.961
    },
    {
        "text": "and find even better treatments aldo has",
        "start": 159.68,
        "duration": 6.48
    },
    {
        "text": "been back on adukanymab for six months",
        "start": 163.2,
        "duration": 5.28
    },
    {
        "text": "and says he's already beginning to feel",
        "start": 166.16,
        "duration": 3.2
    },
    {
        "text": "the benefits",
        "start": 168.48,
        "duration": 2.8
    },
    {
        "text": "i've noticed that i'm getting less",
        "start": 169.36,
        "duration": 4.0
    },
    {
        "text": "confused although it's still there",
        "start": 171.28,
        "duration": 5.44
    },
    {
        "text": "it's not quite as bad and i'm just",
        "start": 173.36,
        "duration": 5.68
    },
    {
        "text": "feeling that bit more confident now",
        "start": 176.72,
        "duration": 4.96
    },
    {
        "text": "adukanemab is suitable only for those",
        "start": 179.04,
        "duration": 4.559
    },
    {
        "text": "with mild alzheimer's",
        "start": 181.68,
        "duration": 4.4
    },
    {
        "text": "when damage to brain function is still",
        "start": 183.599,
        "duration": 3.521
    },
    {
        "text": "limited",
        "start": 186.08,
        "duration": 3.6
    },
    {
        "text": "it could take more than a year before uk",
        "start": 187.12,
        "duration": 3.6
    },
    {
        "text": "regulators",
        "start": 189.68,
        "duration": 3.76
    },
    {
        "text": "decide whether to approve the drug if",
        "start": 190.72,
        "duration": 3.599
    },
    {
        "text": "they do",
        "start": 193.44,
        "duration": 4.4
    },
    {
        "text": "demand here will be enormous",
        "start": 194.319,
        "duration": 8.081
    },
    {
        "text": "bbc news well as we've reported some",
        "start": 197.84,
        "duration": 7.84
    },
    {
        "text": "experts advised against this drug being",
        "start": 202.4,
        "duration": 5.199
    },
    {
        "text": "approved and i spoke to one of them dr",
        "start": 205.68,
        "duration": 5.04
    },
    {
        "text": "g calib alexander he told me he was",
        "start": 207.599,
        "duration": 5.28
    },
    {
        "text": "shocked at the decision by the fda to",
        "start": 210.72,
        "duration": 3.76
    },
    {
        "text": "approve it",
        "start": 212.879,
        "duration": 3.761
    },
    {
        "text": "um this was not the outcome that i",
        "start": 214.48,
        "duration": 3.36
    },
    {
        "text": "expected",
        "start": 216.64,
        "duration": 4.4
    },
    {
        "text": "uh nor that i was encouraging the fda to",
        "start": 217.84,
        "duration": 4.08
    },
    {
        "text": "consider",
        "start": 221.04,
        "duration": 3.04
    },
    {
        "text": "uh i think the jury is still out",
        "start": 221.92,
        "duration": 3.76
    },
    {
        "text": "regarding this product and",
        "start": 224.08,
        "duration": 3.92
    },
    {
        "text": "and there's remarkable uh there's a",
        "start": 225.68,
        "duration": 4.08
    },
    {
        "text": "remarkable amount of uncertainty",
        "start": 228.0,
        "duration": 3.92
    },
    {
        "text": "regarding the totality of evidence",
        "start": 229.76,
        "duration": 4.32
    },
    {
        "text": "as to whether it truly is effective or",
        "start": 231.92,
        "duration": 4.399
    },
    {
        "text": "not well just talk us through that",
        "start": 234.08,
        "duration": 5.359
    },
    {
        "text": "because the fda has voted",
        "start": 236.319,
        "duration": 6.241
    },
    {
        "text": "against licensing this in the past",
        "start": 239.439,
        "duration": 6.481
    },
    {
        "text": "so have has have the facts changed",
        "start": 242.56,
        "duration": 4.959
    },
    {
        "text": "for them to make a different decision",
        "start": 245.92,
        "duration": 3.28
    },
    {
        "text": "now",
        "start": 247.519,
        "duration": 3.36
    },
    {
        "text": "well it's a great question and i think",
        "start": 249.2,
        "duration": 3.44
    },
    {
        "text": "we'll have to find out and look",
        "start": 250.879,
        "duration": 3.36
    },
    {
        "text": "carefully at the materials that",
        "start": 252.64,
        "duration": 3.36
    },
    {
        "text": "accompany this decision",
        "start": 254.239,
        "duration": 3.84
    },
    {
        "text": "to see whether additional data has been",
        "start": 256.0,
        "duration": 4.479
    },
    {
        "text": "provided by the manufacturer",
        "start": 258.079,
        "duration": 4.881
    },
    {
        "text": "but i was part of a scientific advisory",
        "start": 260.479,
        "duration": 3.201
    },
    {
        "text": "committee",
        "start": 262.96,
        "duration": 3.2
    },
    {
        "text": "late last year and there was virtual",
        "start": 263.68,
        "duration": 3.44
    },
    {
        "text": "consensus",
        "start": 266.16,
        "duration": 3.28
    },
    {
        "text": "among the committee that there simply",
        "start": 267.12,
        "duration": 3.04
    },
    {
        "text": "was not",
        "start": 269.44,
        "duration": 3.92
    },
    {
        "text": "a persuasive evidence uh persuasive is",
        "start": 270.16,
        "duration": 4.64
    },
    {
        "text": "the key term there",
        "start": 273.36,
        "duration": 3.76
    },
    {
        "text": "uh and that's a regulatory threshold and",
        "start": 274.8,
        "duration": 3.44
    },
    {
        "text": "and so the committee",
        "start": 277.12,
        "duration": 4.16
    },
    {
        "text": "uh there was pretty much uh agreement",
        "start": 278.24,
        "duration": 4.16
    },
    {
        "text": "among the committee",
        "start": 281.28,
        "duration": 2.639
    },
    {
        "text": "that at that time there was not",
        "start": 282.4,
        "duration": 3.2
    },
    {
        "text": "persuasive evidence",
        "start": 283.919,
        "duration": 4.241
    },
    {
        "text": "that this product was safe and effective",
        "start": 285.6,
        "duration": 6.4
    },
    {
        "text": "and therefore suitable for market access",
        "start": 288.16,
        "duration": 6.24
    },
    {
        "text": "dr g caliber alexander spoke to me",
        "start": 292.0,
        "duration": 4.08
    },
    {
        "text": "earlier i also caught up with maria",
        "start": 294.4,
        "duration": 2.88
    },
    {
        "text": "acarillo's chief",
        "start": 296.08,
        "duration": 2.64
    },
    {
        "text": "science officer at the alzheimer's",
        "start": 297.28,
        "duration": 3.28
    },
    {
        "text": "association in the united states and she",
        "start": 298.72,
        "duration": 2.8
    },
    {
        "text": "disagreed",
        "start": 300.56,
        "duration": 3.359
    },
    {
        "text": "with that argument put forward by dr",
        "start": 301.52,
        "duration": 4.0
    },
    {
        "text": "alexander",
        "start": 303.919,
        "duration": 3.361
    },
    {
        "text": "of course of the alzheimer's association",
        "start": 305.52,
        "duration": 3.76
    },
    {
        "text": "and the largest patient advocacy group",
        "start": 307.28,
        "duration": 5.919
    },
    {
        "text": "um we are celebrating this as a victory",
        "start": 309.28,
        "duration": 5.919
    },
    {
        "text": "for the millions of americans and",
        "start": 313.199,
        "duration": 3.521
    },
    {
        "text": "actually the millions of individuals",
        "start": 315.199,
        "duration": 4.241
    },
    {
        "text": "all around the world who uh experience",
        "start": 316.72,
        "duration": 4.319
    },
    {
        "text": "alzheimer's in their family this is a",
        "start": 319.44,
        "duration": 3.36
    },
    {
        "text": "family disease and it's devastating",
        "start": 321.039,
        "duration": 4.16
    },
    {
        "text": "so we are celebrating a victory today",
        "start": 322.8,
        "duration": 4.72
    },
    {
        "text": "but but scientifically speaking",
        "start": 325.199,
        "duration": 5.361
    },
    {
        "text": "what has changed between that committee",
        "start": 327.52,
        "duration": 6.0
    },
    {
        "text": "review which dr alexander sat on a few",
        "start": 330.56,
        "duration": 4.079
    },
    {
        "text": "months ago",
        "start": 333.52,
        "duration": 4.64
    },
    {
        "text": "and now so i don't think anything has",
        "start": 334.639,
        "duration": 5.201
    },
    {
        "text": "changed what it really is is the",
        "start": 338.16,
        "duration": 3.84
    },
    {
        "text": "interpretation of that data",
        "start": 339.84,
        "duration": 4.079
    },
    {
        "text": "and that is just an interpretation that",
        "start": 342.0,
        "duration": 2.96
    },
    {
        "text": "comes from looking at it from two",
        "start": 343.919,
        "duration": 2.161
    },
    {
        "text": "different sides",
        "start": 344.96,
        "duration": 2.88
    },
    {
        "text": "um so the fda has a certain side and",
        "start": 346.08,
        "duration": 3.04
    },
    {
        "text": "they've shared it today",
        "start": 347.84,
        "duration": 3.28
    },
    {
        "text": "through their approval we also uh we're",
        "start": 349.12,
        "duration": 3.2
    },
    {
        "text": "looking at this",
        "start": 351.12,
        "duration": 4.72
    },
    {
        "text": "as a half glass full this approval which",
        "start": 352.32,
        "duration": 5.2
    },
    {
        "text": "the advisory committee actually did not",
        "start": 355.84,
        "duration": 3.12
    },
    {
        "text": "consider was",
        "start": 357.52,
        "duration": 4.0
    },
    {
        "text": "granted under what's called accelerated",
        "start": 358.96,
        "duration": 4.16
    },
    {
        "text": "approval it's a special program",
        "start": 361.52,
        "duration": 4.64
    },
    {
        "text": "within the fda that allows for",
        "start": 363.12,
        "duration": 6.079
    },
    {
        "text": "diseases with severe unmet needs to",
        "start": 366.16,
        "duration": 4.56
    },
    {
        "text": "actually be approved",
        "start": 369.199,
        "duration": 3.921
    },
    {
        "text": "under this accelerated approval process",
        "start": 370.72,
        "duration": 3.919
    },
    {
        "text": "that is a bit conditional",
        "start": 373.12,
        "duration": 3.44
    },
    {
        "text": "because it will require confirmatory",
        "start": 374.639,
        "duration": 4.321
    },
    {
        "text": "trials later but it allows diseases",
        "start": 376.56,
        "duration": 4.479
    },
    {
        "text": "like alzheimer's that kill with it",
        "start": 378.96,
        "duration": 3.76
    },
    {
        "text": "that's critical unmet need we have",
        "start": 381.039,
        "duration": 2.961
    },
    {
        "text": "nothing to slow",
        "start": 382.72,
        "duration": 3.759
    },
    {
        "text": "down this disease at all to have an",
        "start": 384.0,
        "duration": 4.08
    },
    {
        "text": "opportunity of these patients to have an",
        "start": 386.479,
        "duration": 3.761
    },
    {
        "text": "opportunity for treatment now",
        "start": 388.08,
        "duration": 3.679
    },
    {
        "text": "rather than wait another five years for",
        "start": 390.24,
        "duration": 3.6
    },
    {
        "text": "a confirmatory trial like dr alexander",
        "start": 391.759,
        "duration": 3.28
    },
    {
        "text": "and others are calling for",
        "start": 393.84,
        "duration": 3.68
    },
    {
        "text": "when it would be too late for them to",
        "start": 395.039,
        "duration": 3.681
    },
    {
        "text": "actually have",
        "start": 397.52,
        "duration": 4.399
    },
    {
        "text": "access and and have a benefit from this",
        "start": 398.72,
        "duration": 4.64
    },
    {
        "text": "treatment",
        "start": 401.919,
        "duration": 4.481
    },
    {
        "text": "maria carrillo",
        "start": 403.36,
        "duration": 3.04
    }
]